SciBase's EIS Technology Selected as Primary Endpoint in NIH Skin Barrier Study

PartnershipPositive

AI Analysis

Summary

SciBase announced its EIS Technology has been selected as the primary endpoint in a new NIH-led skin barrier study, marking a collaboration to advance detection and prevention in dermatology.

Clinical Trial Data

Importance:5/10

Sentiment:

0.60

dermatologyAI-based deviceNIH collaborationskin barrierprimary endpoint selection

Related Companies

$SCIB $NHPAP

Read the original article

Published by PR Newswire Biotech on October 15, 2026 6:12 AM

Read Original